Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Interleukin 1-alpha Is Critical for Establishment of Inflammatory Lung Disease

Lara C. Pullen, PhD  |  January 21, 2014

The fibroblast is typically considered a structural cell that contributes to lung repair. This study suggests that the lung fibroblast has innate immune function and can release inflammatory mediates at a level on par with professional innate immune cells such as macrophages. IL-1α appears to play a pivotal role in triggering the proinflammatory response in fibroblasts.

“Our observations raise the possibility that the resident lung fibroblasts may provide the immediate inflammatory response to any epithelial barrier injury and attract and activate myeloid cells with killing capacity into the vicinity to protect against infection while the integrity of the barrier function is re-established,” wrote Dr. Fisher.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Pullen is a medical writer based in the Chicago area.

Reference

  1. Suwara MI, Green NJ, Borthwick LA, et al. IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. Mucosal Immunol. 2013 Oct 30. [Epub ahead of print]

 

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 | Single Page
Share: 

Filed under:Research Rheum Tagged with:COPDfibroblastsInterleukinpulmonary fibrosis

Related Articles

    What Fat Does to Arthritis

    August 1, 2011

    The role of adipokines in the pathogenesis of rheumatic diseases

    Alpha Tauri 3D Graphics / shutterstock.com

    Study Elucidates Potential Flare Pathways in Rheumatoid Arthritis

    December 14, 2020

    Research in The New England Journal of Medicine has opened new avenues for exploring the pathophysiology of disease flares in rheumatoid arthritis.1 Through longitudinal genomic analysis, researchers have identified a naive B cell signature prior to rheumatoid arthritis flares, as well as a type of mesenchymal cell, that may play an important role in flare…

    T Cells in Systemic Lupus Erythematosus

    August 1, 2011

    Progress toward targeted therapy

    How a Nuclear Molecule Alarms the Immune System

    August 1, 2011

    The role of HMGB1 in the pathogenesis of lupus nephritis

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences